| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 0.610 | 0.692 | 2.5E-16 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
muscle associated receptor tyrosine kinase | 0.570 | 0.769 | 4.2E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
discoidin domain receptor tyrosine kinase 2 | 0.541 | 0.769 | 0.55 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
dynein cytoplasmic 2 light intermediate chain 1 | 0.601 | 0.500 | 3.2E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha | 0.633 | 0.692 | 1.0E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FAM20C golgi associated secretory pathway kinase | 0.578 | 0.731 | 0.31 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
small nuclear ribonucleoprotein polypeptides B and B1 | 0.595 | 0.731 | 0.71 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cilia and flagella associated protein 410 | 0.633 | 0.615 | 3.3E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
dynein cytoplasmic 2 heavy chain 1 | 0.555 | 0.731 | 1.1E-44 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
centrosome and spindle pole associated protein 1 | 0.544 | 0.769 | 3.3E-29 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 10 member 7 | 0.711 | 0.269 | 2.0E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
matrilin 3 | 0.644 | 0.385 | 1.4E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
heparan sulfate proteoglycan 2 | 0.438 | 0.885 | 1.0E-19 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
hydroxysteroid 17-beta dehydrogenase 4 | 0.546 | 0.654 | 2.4E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 43 | 0.617 | 0.577 | 1.8E-11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BMP binding endothelial regulator | 0.641 | 0.577 | 6.6E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 26 member 2 | 0.553 | 0.692 | 7.5E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
transmembrane anterior posterior transformation 1 | 0.674 | 0.538 | 3.2E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
filamin B | 0.458 | 0.923 | 6.1E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 172 | 0.582 | 0.654 | 3.3E-33 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
glucosylceramidase beta | 0.500 | 0.808 | 1.4E-06 |
|
disease | 0.100 | None | 0 | 0 |